SMAD3 and Hyperglycemia: Hyperglycemia drives renal injury through activation of the RAAS and accumulation of advanced glycation end products (AGEs), while aberrant activation of key signaling pathways such as TGF-β/Smad3 and NF-κB further promotes renal fibrosis.